Publication at Faculty of Medicine in Pilsen |
2016
Abstract
The autohors sumarize Their clinical and laboratory experience with idaricizumab, a specific monoclonal antibody agains dabigatran - the first direct oral thrombin inhibitor.
The autohors sumarize Their clinical and laboratory experience with idaricizumab, a specific monoclonal antibody agains dabigatran - the first direct oral thrombin inhibitor.